Dirk FeyGroup Leader
Stephanie McKennaPh.D. Student, Fey/Gomez Matallanas Groups
Annabelle NwaokoriePh.D. Student, Fey Group
About the Group
What we do
We are always looking for talented people to join our team - contact Dirk.
For a complete list see Google Scholar
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients.
D Fey, M Halasz, …, DR Croucher.
Science Signalling 8 (408). PMID: 26696630
On the personalised modelling of cancer signalling.
D Fey, A Kuehn, BN Kholodenko.
IFAC-PapersOnLine 49 (26), 312-317.
The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells.
D Fey, D Matallanas, J Rauch, OS Rukhlenko, BN Kholodenko.
Seminars in cell & developmental biology 58, 96-107. 2016. PMID: 27350026
Frequency modulation of ERK activation dynamics rewires cell fate.
H Ryu, M Chung, M Dobrzyński, D Fey, ..., O Pertz.
Molecular systems biology 11 (11), 838. 2015. PMID: 26613961
Crosstalk and signaling switches in mitogen-activated protein kinase cascades.
D Fey, DR Croucher, W Kolch, BN Kholodenko.
Frontiers in physiology 3, 355-355. 2012. PMID: 23060802
SBI Blog: Personalised modelling predicts neuroblastoma survival | January 2016
SBI Blog: Timing matters: Pulses of EGF hormone trick cells into becoming neurons | December 2015
SBI Blog: Why march for science? | April 2017
SBI Blog: US Cancer Moonshot Initiative: A cancer scientist's perspective | video, January 2016
SBI Blog: From Systems Biology to Systems Medicine; a conversation with Pathologist Prof. David Harrison | video, March 2015
SystemsMedicine.net: 10 questions to Dr Dirk Fey | August 2015
SystemsMedicine.net: 10 Questions Science: Personalised modelling predicts neuroblastoma survival | January 2016
genomeweb: Researchers model JNK signaling to predict survival in neuroblastoma | December 2015
Irish Medical Times: The digital future of healthcare in Ireland | March 2015